View of Relative bioavailability/bioequivalence between two oral formulations of rivaroxaban (20 mg) in healthy brazilian subjects, under fasting and fed conditions

Return to Article Details Relative bioavailability/bioequivalence between two oral formulations of rivaroxaban (20 mg) in healthy brazilian subjects, under fasting and fed conditions Download Download PDF